The gap between scientific credibility and commercial reality has rarely been as wide as it is for D-Wave Quantum. The company has spent the past several weeks collecting validation from some of the most respected institutions in the world, yet its stock remains deep in the red for the year and its income statement still shows a business that has yet to turn its promise into profit.
That disconnect is the central tension for anyone following this stock, and the latest developments only sharpen it.
Two Governments, Two Grants, One Strategy
D-Wave has secured public research funding from both sides of the Canada-US border, a sign that policymakers see the company as a strategic player in the quantum race. The Canadian National Research Council has approved up to 300,000 Canadian dollars — roughly 299,000 US dollars — through its Applied Quantum Computing Challenge Program. That money will go toward developing graph-minor-embedding algorithms for D-Wave’s Zephyr topology and integrating them into the company’s open-source Ocean SDK. The work is being carried out at the Quantum Centre of Engineering Excellence in Burnaby, British Columbia, with the goal of tackling larger, more complex optimization problems on the Advantage2 systems, which pack more than 4,400 qubits. Logistics, manufacturing, finance, machine learning, and quantum simulation are all cited as target applications.
Meanwhile, the US National Science Foundation has confirmed a $1.57 million grant for the ERASE project, a fault-tolerant quantum computing initiative led by Yale University. D-Wave’s involvement runs through its Quantum Circuits subsidiary, which will provide access to a superconducting dual-rail gate-model system — a fundamentally different technical approach from the annealing technology that built D-Wave’s reputation. The project also has a workforce development component, aimed at training the next generation of quantum engineers.
Trevor Lanting, D-Wave’s head of technology development, framed the Canadian grant as evidence that software innovation is the key to expanding quantum computing’s commercial impact. That emphasis is telling: the company is increasingly positioning itself not just as a hardware maker but as a platform play, using developer tools to make its architecture more accessible.
Add to that a non-binding commitment of $100 million under the CHIPS and Science Act, and the picture becomes clear. D-Wave is deliberately hedging its bets, using government support to advance both its established annealing business and its newer gate-model ambitions rather than relying solely on commercial revenue.
The Science That Shook the Narrative
The grants arrived on the heels of a more tangible scientific achievement. D-Wave published research in one of the world’s most prestigious scientific journals describing a fast, high-precision two-qubit gate for superconducting dual-rail cavity qubits. For a company long dismissed as a niche annealing specialist, that is a significant statement of intent — a signal that it can compete in the gate-model arena where IBM and Google have dominated the headlines.
The paper also lends credibility to the January acquisition of Quantum Circuits, suggesting the deal brought genuine research substance rather than just balance-sheet optics. The Yale connection through the NSF grant reinforces that point: D-Wave is now embedded in the academic ecosystem in a way it never was before.
On the commercial front, the Florida Atlantic University deal stands out. The university paid $20 million for an Advantage2 system with over 4,400 qubits, making it the first university in Florida to operate such a machine. CEO Alan Baratz has pointed to six customer applications now in production, with growing interest from large enterprises.
The Numbers Tell a More Complicated Story
For all the scientific momentum, the second quarter of 2026 was a reminder of how far D-Wave is from becoming a conventional growth story. Revenue came in at $3.1 million, essentially flat year over year and well short of the $4.03 million consensus estimate. The stock dropped about 9 percent in response.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
But the revenue line obscures what may be the quarter’s real headline: bookings. First-half bookings surged 1,120 percent year over year to $35.5 million, while backlog climbed 668 percent to $40.7 million. These are the numbers that growth investors tend to focus on — the difference between what a company earned yesterday and what it might earn tomorrow.
The balance sheet remains a source of comfort, though it’s thinning. As of June 30, D-Wave held $546.2 million in cash and securities, down $273.1 million from a year earlier, with over 90 percent of that decline attributable to the cash portion of the Quantum Circuits acquisition. Given an adjusted EBITDA loss that widened 85 percent to $37.1 million, that cash cushion buys time — but it also buys a finite amount of it.
Insider Selling Complicates the Optimism
Here’s where the story gets harder to read. Over the past 90 days, D-Wave insiders have sold roughly $28 million to $30 million worth of stock on a net basis, including significant transactions from Baratz and CFO John Markovich. There have been no insider purchases.
That pattern doesn’t necessarily signal trouble — executives routinely diversify after a stock run-up — but it sits awkwardly alongside the relentlessly upbeat narrative coming from management. When the people closest to the company are selling while the company itself is touting record bookings and scientific breakthroughs, it’s reasonable for investors to ask what they know.
The roadmap management has laid out is nothing if not ambitious: a 17-qubit gate system by the end of this year, a 49-qubit system in 2027 with a targeted 20-fold error reduction, and on the annealing side, 20,000 qubits by 2029 and 100,000 by 2031. Those are the kind of targets that will ultimately determine whether scientific prestige translates into commercial substance.
A Stock That Moves on News
The market’s reaction to the recent grant announcements has been muted but positive. The stock closed Wednesday at €17.96 in German trading, up 2.5 percent on the day. Over the past 30 days, it has gained 8.0 percent, though it remains roughly 21 percent below its level at the start of the year.
The share price of €18.02 sits about 55 percent below its 52-week high of €40.41 from October — a reminder of just how volatile this sector can be. With annualized volatility of 105 percent, D-Wave’s stock is hypersensitive to individual headlines, whether they concern grants, earnings, or insider transactions.
Analysts remain cautiously constructive, with a consensus of “Moderate Buy” and price targets from firms like Wedbush and Cantor Fitzgerald reaching as high as $40.
The grants themselves are financially modest — the Canadian award is barely a rounding error for a company burning through tens of millions per quarter. What they represent matters more: institutional confidence in D-Wave’s technological direction, from both governments and leading academic institutions. Whether that confidence eventually shows up in the income statement is the question that will define this stock for the foreseeable future.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from August 13 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 13.
D-Wave Quantum: Buy or sell? Read more here...
